Results for CytomX Therapeutics

Add to feed Create your own feed

Most relevant

Cytomx Therapeutics CEO Sean McCarthy told BioWorld that the longish hiatus between deals broken by the tie-up with Astellas Pharma was “very deliberate."

$CTMX: CytomX Therapeutics and Astellas announce strategic collaboration to develop Probody T-Cell engaging...

After losing its CMO last summer, CytomX Therapeutics finally nabs a replacement

tweet picture

$CTMX CytomX Therapeutics#IPO  - $BMY has indicated interest in purchasing up to $10M in shares in offering, $PFE up to $5M.

Loading
Loading